Life Light protocol #1 is for circulation. Red light therapy, as it is commonly known, or low level light therapy (LLLT) or Photobiomodulation, has an incredible impact on circulation. The Life Light circulation protocol extends those benefits even further.
Localized Application and Systemic Effects
When red or near-infrared light penetrates the skin, it initiates a cascade of biological responses that fundamentally enhance how blood moves through your tissues. Photobiomodulation (PBM) therapy—the clinical application of specific wavelengths of light to treat various conditions—has emerged as a powerful, non-invasive method to improve both local and systemic circulation. Even when applied to a relatively small area of approximately 0.25 square feet (roughly 232 cm²), PBM can trigger remarkable vascular changes that extend well beyond the treatment site.
This article explores the evidence-based mechanisms through which PBM enhances blood circulation, the rapid timeline of circulatory improvements, and the clinical implications for pain management, wound healing, and overall tissue health.
The primary mechanism by which PBM enhances circulation centers on nitric oxide (NO), a critical signaling molecule that regulates vascular tone. Under conditions of cellular stress, injury, or inflammation, nitric oxide becomes reversibly bound to cytochrome c oxidase (CcO)—the terminal enzyme in the mitochondrial electron transport chain. This binding inhibits cellular respiration, reduces ATP production, and constricts blood vessels.
When tissue absorbs photons of red (630–660 nm) or near-infrared (810–880 nm) light, a photochemical reaction occurs: light energy displaces bound nitric oxide from CcO, releasing it into the surrounding tissue. This liberated NO diffuses into the smooth muscle cells lining blood vessel walls, triggering relaxation. The result is vasodilation—the widening of arterioles, capillaries, and venules—which dramatically increases local blood flow.
Research demonstrates that PBM produces both immediate and prolonged circulatory improvements. In a 2020 randomized controlled trial, investigators applied near-infrared light (830 nm) to the wrist for just five minutes and monitored downstream effects in the palm using laser Doppler flowmetry and photoplethysmography.
Key findings included:
• 27% increase in microcirculatory blood flow during irradiation
• 54% increase in blood flow persisting 20 minutes after treatment cessation
• Mean time to 20% flow increase: less than 2.5 minutes from treatment initiation
• Increased blood volume and velocity in capillary beds
Importantly, these circulatory benefits were sustained well after light exposure ended, indicating that PBM triggers lasting physiological changes rather than transient effects.
When PBM is applied to approximately 0.25 square feet of body surface—an area comparable to treating a shoulder, knee, or large muscle group—the localized vascular response includes:
1. Arteriolar dilation: Increased oxygen and nutrient delivery
2. Enhanced capillary flow: Improved density and perfusion rate of the microcirculatory network
3. Increased tissue oxygenation: Higher hemoglobin saturation as flow accelerates
4. Accelerated metabolic waste removal: Faster clearance of carbon dioxide, lactate, and inflammatory mediators
Thermal imaging studies reveal that responders to PBM therapy experience local skin temperature increases of at least 0.5°C, reflecting enhanced blood flow beneath the skin surface. This warming effect typically appears within minutes and serves as a clinical indicator of successful vascular modulation.
Optimal responders have peripheral skin temperatures between 33–37.5°C. Individuals with very cold extremities (<33°C) or elevated temperatures (>37.5°C) may show attenuated responses, suggesting PBM works best when the vascular system retains flexibility for modulation.
While PBM’s most pronounced circulatory benefits occur directly under the light source, emerging evidence reveals systemic effects that extend throughout the body. Cells within blood and lymphatic fluid that absorb photons during treatment can travel to distant sites, carrying beneficial biochemical signals.
Preclinical and early clinical evidence indicates that local PBM irradiation can increase circulating adenosine, growth hormone, and fibroblast growth factor within hours; promote collateral circulation in distant tissues; enhance lymphatic drainage; and modulate systemic cytokines (IL-6, IL-8, TNF-α).
Improved microcirculation influences numerous clinical conditions. By reducing vascular resistance and enhancing endothelial function, PBM may help lower blood pressure, reduce clot risk, and support cardiovascular and lymphatic health.
Chronic pain conditions—especially musculoskeletal disorders—are often linked to reduced circulation. Ischemic tissues accumulate pain-inducing metabolites such as prostaglandins and bradykinin. By restoring blood flow, PBM helps clear inflammatory mediators, deliver oxygen, reduce edema, and modulate pain signaling.
Adequate blood supply is essential for healing. PBM accelerates tissue repair through angiogenesis, fibroblast activation, immune cell recruitment, and reduced necrosis. Clinical studies show faster healing in surgical wounds, diabetic ulcers, and burns with PBM treatment.
Athletes using PBM pre- and post-exercise benefit from improved oxygen delivery, reduced muscle soreness, faster recovery from microtrauma, and prevention of overuse injuries.
Based on current evidence, the following parameters maximize circulatory benefits:
• Red light (630–660 nm): Ideal for superficial tissues (0–5 mm depth)
• Near-infrared (810–880 nm): Penetrates deeper (5–40 mm) for strong microcirculatory effects
• Energy density: 2–10 J/cm² per session (under 1 J/cm² may be insufficient; over 50 J/cm² may inhibit response)
• Treatment frequency: Daily for acute cases; 3–5 sessions per week for chronic; 1–2 sessions weekly for maintenance
• Maintain consistent device distance (0–15 cm from skin) and ensure full coverage of target area
PBM therapy demonstrates an exceptional safety profile. The most common effect is mild, transient skin warming—a therapeutic response, not an adverse event. Eye protection is recommended during use.
Contraindications include: active cancer in treatment area, pregnancy (over abdomen), photosensitizing medications, and epilepsy for transcranial use.
Even when applied to a modest 0.25-square-foot area, PBM therapy delivers systemic circulatory benefits. Through nitric oxide-mediated vasodilation, improved microcirculatory perfusion, and biochemical signaling, PBM offers a drug-free, non-invasive method to enhance blood flow locally and systemically.
Applications include accelerated wound healing, pain reduction, athletic performance, and cardiovascular support. As our understanding of vascular photobiology grows, clinicians can increasingly harness PBM for precise, patient-centered care.
• Microcirculatory Response to Photobiomodulation: A Randomized Controlled Study – PubMed (https://pubmed.ncbi.nlm.nih.gov/32064652/)
• Low-level laser therapy accelerates collateral circulation and enhances microcirculation – PubMed (https://pubmed.ncbi.nlm.nih.gov/15954817/)
• Effectiveness of Photobiomodulation Therapy in Fibromyalgia Syndrome: A Systematic Review – MDPI (https://www.mdpi.com/2076-3417/15/8/4161)
• Shining Light on the Head: Photobiomodulation for Brain Disorders – ScienceDirect (https://www.sciencedirect.com/science/article/pii/S2214647416300381)
• Assessment of Photobiomodulation in Arteriovenous Fistula Microcirculation – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11994221/)
© All rights reserved
COPYRIGHT © 2018 · INFORMATION ON THIS SITE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND IS NOT MEANT TO SUBSTITUTE FOR THE ADVICE PROVIDED BY YOUR OWN PHYSICIAN OR OTHER MEDICAL PROFESSIONAL. THE RESULTS REPORTED MAY NOT NECESSARILY OCCUR IN ALL INDIVIDUALS. THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA. LIFE LIGHT DEVICES ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.